Risk factors
Beta Bionics (BBNX) risk factors
Item 1A of every Beta Bionics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors105 risks13 new6 dropped13 reworded
Beta Bionics faces new risks regarding international tariffs on iLet components from China and CMS reimbursement rule changes.
Filed Feb 24, 2026 - FY2024 10-K risk factors98 risks
Beta Bionics faces significant operating losses, an accumulated deficit of $296.7 million, and relies solely on sales of its recently launched iLet bionic pancreas.
Filed Mar 25, 2025